Empowering the Frontline Care Team in the Battle Against HIV
The Forefront HIV Care Summit takes center stage as the leading and exclusive conference in the United States, devoted entirely to the dedicated frontline care team and its invaluable members responsible for the well-being of individuals living with or susceptible to HIV. With a focus on fostering real progress, this exceptional summit serves as a conduit for cutting-edge discoveries and research breakthroughs that can be seamlessly transformed into practical applications within the clinical sphere. Prepare to join a diverse community of healthcare professionals at this paramount event, where innovative ideas and evidence-based insights converge to shape a brighter future for those impacted by HIV.
ACTHIV™ 2023 is pleased to announce this year’s satellite symposia.
The American Conference for the Treatment of HIV™ (ACTHIV™) is the premier conference in the US dedicated exclusively to the frontline care team and its members who are caring for persons living with or at risk of acquiring HIV. The conference delivers information on new developments and research findings that can be rapidly translated and directly applied to the clinical setting. The conference will take place May 4 – 6, 2023 at the Sheraton Phoenix Downtown Hotel.
The following events are not part of the official ACTHIV™ conference, as planned by ACTHIV™ Program Committee. They are being offered as supplemental learning opportunities for attendees of the conference.
Thursday, May 4, 2023
Breakfast symposium presented by ViiV Healthcare
7:15 AM – 8:15 AM MST
It Starts With a Conversation: An in-depth review of new clinical data and patient preference for a long-acting HIV treatment
Matthew H. Herrmann, MD, AAHIVS, Infectious Disease Specialist
Mark Lewandowski, PharmD, AAHIVE, ViiV Healthcare Medical Director
Luncheon symposium presented by ViiV Healthcare
12:00 PM – 1:00 PM MST
PrEP today. Data discussions on an HIV-1 PrEP option
Session Description: During this educational session, attendees will learn about an alternative PrEP option to help prevent HIV in their patients. The program will review important information, clinical data, and dosing and administration, and provide guidance on identifying patients who would benefit.
Doug Cunningham, DO
Pueblo Family Physicians
Robert Morris, PharmD
ViiV Healthcare Medical Presenter
PrEP Ambassador: Stephon
Friday, May 5, 2023
Luncheon symposium sponsored by Merck & Co., Inc.
12:45 PM – 1:45 PM MST
Invasive Pneumococcal Disease in Adults: Key Serotypes and the Role of Immune Response
- Increase awareness about key serotypes in adult IPD burdern
- Review data supporting an option aligned to CDC recommendations to help prevent adult IPD
- Discuss implementation strategies for clinical practice
Robert G Feldman, MD
Friday, May 5, 2023
Reception symposium sponsored by Gilead Sciences
5:15 PM – 6:15 PM MST
Treatment Options to Help Support Different HIV Populations
Ann Khalsa, MD, MSEd, FAAFP, AAHIVS
Medical Director, McDowell Community Health Center